Insurance and Superannuation » Pancare Foundation

Home » Living well » Practical support » Finances » Insurance and Superannuation

DISCLAIMER: Information provided by the Pancare Foundation is not a substitute for medical advice, diagnosis, treatment, or other health care services. Pancare Foundation may provide information to you about physicians, products, services, clinical trials, or treatments related to upper gastrointestinal cancers, but the Pancare Foundation does not recommend nor endorse any healthcare resource if not specified.

ARTICLES, NEWS & EVENTS

December 18, 2023 // Latest news

Have your say on treatments that matter to you

Patients and their families impacted by upper gastrointestinal (GI) cancers are invited to share their lived experience on two therapies that are listed in the upcoming Pharmaceutical Benefits Advisory Committee (PBAC) meeting in March 2024.

June 20, 2022 // Latest news

Unite for Hope 2022: Echuca, Mansfield, Sydney and beyond!

Our Unite for Hope fundraisers have raised nearly $70,000 so far! These vital funds help Pancare provide patient support services and fund research into early detection and new treatments. Our passionate community of supporters in Echuca, Mansfield and Sydney braved chilly mornings, muddy fields and howling winds to unite in hope and bring greater awareness, attention and change for upper GI cancers.

April 3, 2024 // Latest news

April is Oesophageal Cancer Awareness Month.

Oesophageal Cancer is considered a rare cancer with low survival rates and little recognition. Raising funds and awareness for Oesophageal cancer helps Pancare deliver personalised cancer support through our PanSupport services, increase awareness and amplify our advocacy. Raising awareness of Oesophageal cancer helps us work toward equity in experience and improved outcomes for all patients and their families.

January 24, 2024 // Latest news

February is Gallbladder and Bile Duct Cancer Awareness Month.

This year it is estimated that over 2226 Australians will be diagnosed with either gallbladder or biliary tract cancer. There is no early detection test, and there is a five-year survival rate of just 18.3 per cent. There has never been a more important time to advocate for these cancers.